SCR-LIP-000728 · Claim · machine-readable JSON →

A polymorphism in the interleukin-six gene may be associated with increased lipedema risk.

General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
1 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

2020The role of IL-6 gene polymorphisms in the risk of lipedema — Di Renzo L et al. (2020) · consistent

Evidence (1)

Context (PECO)

Populationwomen with lipedema, normal-weight obesity, or obesity
Conditionlipedema
ExposureIL-6 rs1800795 G allele carriage and DXA body composition indices
Comparatornon-carriers / control groups
Outcomelipedema risk and differential diagnosis accuracy
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log